Generis Knowledge Management Inc. announced today that a top 10 global biotechnology company has chosen CARA to replace their existing Vault system for the distribution of PSURs, EdTs and associated documents to affiliates and distributors.

“Our client is already using CARA on Documentum for their Regulatory Submissions documents, and moving the distribution of controlled documents into CARA means the overall process will be centralized” said James Kelleher, CEO at Generis.  “In addition to all the standard features of CARA, they can leverage the flexible workflow with reporting and tracking, as well as the Portal access for Affiliates and Distributors, to ensure compliance worldwide.”

CARA provides customers an industry-leading, cost-effective and highly flexible user interface, either on premises or in the cloud. CARA not only provides a high degree of ergonomic and functional advantages, but comes with a set of Life Sciences solutions pre-packaged as accelerators or “RapidDeploy” options, including Submission / CTD, Electronic Trial Master File (eTMF), SOPs / Quality Management, and Change Control.

About Generis Knowledge Management, Inc.

Generis has been providing leading-edge software for content management systems including Documentum, SharePoint, Alfresco and Oracle WebCenter since 1997.  The company has more than 50 customers across industries from Federal Government, through Life Sciences and Engineering to Media, Publishing and Financial.  The company is headquartered in Sarasota, FL, and has its principal development centers in Europe.  Customers include 6 of the global top 10 Life Science companies, Federal and State governments, engineering and media companies.

CARA has recently won a number of awards including the Compliance Product of the Year 2014 from Document Manager, and Generis was featured in Forbes in 2015 and also as one of the Top 20 Most Promising CMS Vendors by CIO Review magazine in June 2015, and is shortlisted for 7 Document Manager prizes for 2016. For more information about Generis visit www.generiscorp.com